Use of topical therapies during pregnancy and the postpartum period

Basit Öğe Kaydı
dc.authorscopusid57273361100
dc.authorscopusid55913651500
dc.authorscopusid55392705500
dc.contributor.authorKöroğlu, Erdem
dc.contributor.authorÖzler, Gül Soylu
dc.contributor.authorKonstantinidis, Iordanis
dc.date.accessioned2024-09-19T15:47:05Z
dc.date.available2024-09-19T15:47:05Z
dc.date.issued2022
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractTreatment selection choices during pregnancy should be based on the US Food and Drug Administration (FDA) risk categories. The FDA categorized drugs as A, B, C, D, and X based on animal and human studies. Category D and category X drugs should be avoided during pregnancy, whereas category A and category B drugs are safe to use. Category C drugs should be considered case by case as there are no adequate studies on humans, but animal studies have shown the adverse effects on fetus. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.en_US
dc.identifier.doi10.1007/978-3-031-05303-0_12
dc.identifier.endpage140en_US
dc.identifier.isbn978-303105303-0
dc.identifier.scopus2-s2.0-85153996966en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage133en_US
dc.identifier.urihttps://doi.org/10.1007/978-3-031-05303-0_12
dc.identifier.urihttps://hdl.handle.net/20.500.12483/14962
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringer International Publishingen_US
dc.relation.ispartofENT Diseases: Diagnosis and Treatment during Pregnancy and Lactationen_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDrug therapyen_US
dc.subjectOtolaryngologyen_US
dc.subjectPostpartum perioden_US
dc.subjectPregnancyen_US
dc.subjectTopical administrationen_US
dc.titleUse of topical therapies during pregnancy and the postpartum perioden_US
dc.typeBook Chapteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu